GoPath Diagnostics (@GoPathLabs) header
GoPath Diagnostics (@GoPathLabs) profile picture

Full-service cancer genetics, molecular and anatomic pathology diagnostics laboratory.

Buffalo Grove, IL
Joined March 2017
Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)Photo by GoPath Diagnostics (@GoPathLabs)
A genetic test result is only the start of the conversation. Genetic counselors help patients understand what their results mean and what comes next. On #GeneticCounselorAppreciationDay, we thank those who turn complex data into clear, compassionate guidance.
6
🔬 We are LIVE at the AMP Annual Meeting & Expo in Seattle! Come find us at booth 829! Visit us to explore our OncoTarget Series, designed to provide precision genomic profiling for advanced cancer. #AMP2026
17
Today, we honor & thank those who have served in the U.S. Armed Forces. We're proud to recognize our own, Mike Ostromecki. Thank you, Mike, for your service to our country & the dedication you bring every day. To all veterans, we extend our gratitude for your service & sacrifice.
5
Behind every diagnosis is a pathologist most patients never meet. This #InternationalPathologyDay, we recognize the professionals whose careful review of a sample can shape an entire treatment plan. Thank you to those who find the answers patients & their teams are waiting for.
14
Not every case of diabetes is type 1 or type 2. This November, during #DiabetesAwarenessMonth, we’re talking about less common forms like #MODY that often go undiagnosed. #GeneticTesting can guide accurate diagnosis & personalized treatment. 🔗 gopathdx.com/diabetesnow
17
GoPath Diagnostics retweeted
Thank you for joining us tonight for our Reception Connection sponsored by @gopath. We are so excited to kick off LUGPA’s Annual Meeting in Chicago. 🥂#LUGPA2026 See you tomorrow!
1
2
160
From research to clinical practice. GoPath Diagnostics & @EndeavorHlth have developed GoProDx™, a first-of-its-kind germline genetic test designed to help predict the risk of aggressive and lethal prostate cancer. Read the full announcement: prnewswire.com/news-releases…
13
Advanced cancers rarely follow a single pattern, which is why detailed genomic profiling matters. Our team will be at booth 829 during the #AMP2026 Annual Meeting to talk about the OncoTarget Series & how it supports #PrecisionOncology.
1
42
Do you know how much a #BRCA1 mutation can raise a person’s cancer risk? Knowing your family’s genetic history is vital to grasping your own. What percentage lifetime risk of breast cancer does an individual with a BRCA1 mutation have? Find the answer 👉 geneticsnow.com/individuals-…
0%5%
0%20%
0%50%
100%80%
1 votes • Final results
11
Diagnosed at 36 with no family history of breast cancer. Sarah’s story from @CDCgov shows how learning she carries a #BRCA1 mutation gave her relatives the chance to learn their own risk & consider prevention options. Read more: cdc.gov/breast-ovarian-cance…
60
We're excited to be attending the AMP Annual Meeting & Expo next month, where we'll showcase our OncoTarget Series. Visit us at booth 829 to learn more about our OncoTarget Series, molecular testing, & biopharma programs. Learn more: gopathdx.com/amp-26
10
Replying to @BCRFcure
@BCRFcure reports that 30 to 50% of breast cancer mutations occur in women who have not traditionally been considered high risk. Its latest article covers research on genes like CHEK2 & PALB2, & how race & ethnicity affect inherited #BreastCancer risk. 🔗 bcrf.org/blog/inherited-risk…
18
GoPath Diagnostics retweeted
Where do your biopsy cores go after they leave the clinic? Find out at booth 203, where TWO-D will be featured inside @GoPathLabs booth at #LUGPA2026! Swing by for a demo & a conversation about protecting biopsy integrity in your practice. Learn more: digitcells.com/twod
1
1
18
Counting down to the 2026 Annual LUGPA Meeting in our hometown of Chicago! Join us as we explore genomic solutions and precision medicine in urology! Our program focuses on enhancing prostate cancer management through innovative tools and tests. 🔗 gopathdx.com/
2
52
Not every breast cancer story begins with a lump. For some families, it starts with a pattern: a mother, an aunt, or a sister diagnosed at a young age. During #BreastCancerAwarenessMonth, we are highlighting the role hereditary risk can play & why knowing it early matters.
22
Our final #KnowYourRisk video examines MMS22L & BIK, two emerging genes still under study. Dr. Helfand explains why these findings are best considered alongside other important factors. Thank you for following along as we help make prostate cancer a little easier to understand.
22
This installment of #KnowYourRisk covers MMS22L & BIK, two emerging genes in #prostatecancer research where the evidence is still developing. Dr. Helfand emphasizes why these results call for caution, & why neither should be treated as a stand-alone, management-changing finding.
22
This installment of #KnowYourRisk covers HSD3B1, a gene tied to how the body responds to hormone therapy rather than inherited cancer risk. Dr. Helfand explains why this result matters most if hormone therapy becomes part of your treatment plan, as it may offer more insight.
16
The next #KnowYourRisk video shifts focus to HSD3B1, a gene tied not to hereditary risk but to hormone sensitivity & ADT response. Dr. Helfand explains why this result is best understood as a hormone-response marker rather than a stand-alone treatment driver.
1
22
Leukemia & Lymphoma Awareness Month is a time to raise awareness of blood cancers & the importance of accurate diagnosis. As testing & treatment continue to advance, earlier & more precise answers can help guide care. Learn more gopathdx.com/blood-cancer #BloodCancerAwareness
24